Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 72888-271

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 72888-271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (390878d2 446f 435d B241 B355caa60aea 38 1)

VENLAFAXINE HYDROCHLORIDE 100 mg extended-release oral capsules. The label displays the product name, strength, dosage form, and labeler Advagen Pharma Ltd. The packaging includes a warning statement and patient information contact details.*

FDA Label Image

Image (390878d2 446f 435d B241 B355caa60aea 38 2)

The image shows a white pharmaceutical bottle with a child-resistant safety cap labeled as VENLAFAXINE HYDROCHLORIDE extended-release capsules. The label specifies the strength as 100 mg per capsule and indicates it is for oral use. The bottle is manufactured by Advagen Pharma Ltd. and has a lot number, expiration date, and NDC barcode visible on the label.*

FDA Label Image

Image (390878d2 446f 435d B241 B355caa60aea 38 3)

VENLAFAXINE HYDROCHLORIDE 150 mg extended release oral capsules bottle label from Advagen Pharma Ltd. The amber plastic bottle includes a white child-resistant cap and contains 100 capsules. The label displays the product name, strength, dosage form, manufacturer, and usage instructions within regulatory compliance.*

FDA Label Image

Image (390878d2 446f 435d B241 B355caa60aea 01)

Chemical structure of venlafaxine hydrochloride, showing its molecular components including a cyclohexane ring, dimethylamino group, methoxybenzene ring, and the hydrochloride component.*

FDA Label Image

Image (390878d2 446f 435d B241 B355caa60aea 02)

A scatter plot chart showing fold change and 90% confidence intervals in pharmacokinetic parameters (Cmax and AUC) for venlafaxine and its ODV metabolite across special populations, including hepatic impairment, renal impairment, CYP2D6 polymorphism, age above 60, and gender differences. The x-axis represents change relative to the reference value.*

FDA Label Image

Image (390878d2 446f 435d B241 B355caa60aea 03)

A scatter plot chart displaying the fold change and 90% confidence intervals for venlafaxine pharmacokinetic parameters (Cmax and AUC) when co-administered with various interacting drugs such as Ethanol, Diazepam, Cimetidine, Ketoconazole (in CYP2D6 extensive and poor metabolizers), Indinavir, Metoprolol, Imipramine, and Lithium. The x-axis represents change relative to the reference value, showing drug interaction effects on venlafaxine exposure.*

FDA Label Image

Image (390878d2 446f 435d B241 B355caa60aea 04)

A dot plot chart showing the fold change and 90% confidence intervals in pharmacokinetic parameters (Cmax and AUC) for various analytes of interacting drugs relative to a reference value. The x-axis represents change relative to the reference value ranging from 0 to 3, with multiple drugs such as ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium included. Each drug's analytes and PK parameters are listed on the left, with corresponding fold change points and error bars on the right.*

FDA Label Image

Image (390878d2 446f 435d B241 B355caa60aea 181 1)

Box packaging for VENLAFAXINE HYDROCHLORIDE extended-release capsules, labeled with a strength of 100 mg. The box displays the labeler Advagen Pharma Ltd. The package design includes the product name in bold capital letters and indicates the dosage form as capsules intended for oral use.*

FDA Label Image

Image (390878d2 446f 435d B241 B355caa60aea 181 2)

The image shows a medication label for VENLAFAXINE HYDROCHLORIDE extended-release capsules, 75 mg strength. The label highlights the 30-count bottle packaging and includes the Advagen Pharma Ltd. labeler information. The capsule dosage form and prescription drug status are visible.*

FDA Label Image

Image (390878d2 446f 435d B241 B355caa60aea 181 3)

VENLAFAXINE HYDROCHLORIDE 75 mg extended release oral capsules packaging label. The white bottle features a label with the product and ingredient name, dosage strength, and capsule form. The labeler is Advagen Pharma Ltd. The container is child-resistant with a white cap.*

FDA Label Image

Venlafaxine-05 (390878d2 446f 435d B241 B355caa60aea 05)

Label for Venlafaxine HCl Extended-release Capsules, USP 37.5 mg by Advagen Pharma Ltd. The label shows NDC 72888-179-30 and contains 30 capsules. It includes storage instructions at 20 to 25°C and a note for pharmacists to dispense the Medication Guide separately. Manufacturer is Inventia Healthcare Limited, India, with distribution by Advagen Pharma Ltd, USA.*

FDA Label Image

Venlafaxine-06 (390878d2 446f 435d B241 B355caa60aea 06)

Label for Venlafaxine Hydrochloride Extended-release Capsules, USP 75 mg, containing 30 capsules. The label includes dosage and storage instructions, pharmacist dispensing guidance, and manufacturer information for Inventia Healthcare Limited. Distributed by Advagen Pharma Ltd., East Windsor, NJ. The label also features the NDC number 72888-180-30 and two barcodes.*

FDA Label Image

Venlafaxine-06 (390878d2 446f 435d B241 B355caa60aea 08)

Label for Venlafaxine HCl Extended-release Capsules, USP, 100 mg strength. The oral capsule packaging contains 30 capsules and is labeled for prescription use only. Manufactured by Inventia Healthcare Limited in India and distributed by Advagen Pharma Ltd. The label includes storage instructions, medication guide information, and barcodes.*

FDA Label Image

150 mg (390878d2 446f 435d B241 B355caa60aea 07)

Label for Venlafaxine HCl extended-release capsules, USP 150 mg, containing 30 capsules. The label includes NDC 72888-181-30, manufacturer Inventia Healthcare Limited, and distributor Advagen Pharma Ltd. It notes storage instructions at controlled room temperature and advises pharmacists to dispense the accompanying medication guide separately.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.